related words |
predictive |
pfizer |
rio |
announce |
bayer |
bm |
biosensor |
hcv |
esw |
careful |
faropenem |
echo |
endpoint |
provenge |
technosphere |
antibiotic |
novogen |
proquin |
mcneil |
ceplene |
|
related documents |
1093649--3/4/2009--IDENIX_PHARMACEUTICALS_INC |
901219--3/2/2010--HUMAN_GENOME_SCIENCES_INC |
1157601--3/26/2009--SYNTA_PHARMACEUTICALS_CORP |
1172480--3/4/2008--SANTARUS_INC |
901219--2/26/2008--HUMAN_GENOME_SCIENCES_INC |
1061983--3/12/2008--CYTOKINETICS_INC |
901219--2/28/2007--HUMAN_GENOME_SCIENCES_INC |
1080014--3/1/2007--THERAVANCE_INC |
901219--3/14/2006--HUMAN_GENOME_SCIENCES_INC |
72444--3/10/2010--NABI__BIOPHARMACEUTICALS |
1080014--2/26/2010--THERAVANCE_INC |
919722--3/15/2010--SUPERGEN_INC |
1172480--3/4/2010--SANTARUS_INC |
1080014--2/27/2009--THERAVANCE_INC |
1157601--3/20/2008--SYNTA_PHARMACEUTICALS_CORP |
1172480--3/6/2009--SANTARUS_INC |
1080014--2/27/2008--THERAVANCE_INC |
1061983--3/12/2009--CYTOKINETICS_INC |
901219--2/26/2009--HUMAN_GENOME_SCIENCES_INC |
1080014--3/8/2006--THERAVANCE_INC |
|
related topics |
{product, candidate, development} |
{provision, law, control} |
{stock, price, operating} |
{stock, price, share} |
{financial, litigation, operation} |
{investment, property, distribution} |
{debt, indebtedness, cash} |
{personnel, key, retain} |
{cost, regulation, environmental} |
{acquisition, growth, future} |
{control, financial, internal} |
{cost, contract, operation} |
{capital, credit, financial} |
{property, intellectual, protect} |
{customer, product, revenue} |
{system, service, information} |
{regulation, government, change} |
{cost, operation, labor} |
{loss, insurance, financial} |
{product, liability, claim} |
|